Clinical Trials Browser

Phase 1 × Neoplasms × Dasatinib × Clear all

Neoplasms

NCT01999985 2020-11-27

Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)

Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Site, Pleural Diseases, Pleural Effusion, Pleural Neoplasms, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms, Pleural Effusion, Malignant

NCT00099606 2011-04-19

Phase I (PH I) Mad Refractory Solid Tumor Study

Phase 1 Completed

60 enrolled

Tumor-Agnostic

Neoplasms

NCT00162214 2011-04-14

Study of Dasatinib in Patients With Advanced Solid Tumors

Phase 1 Terminated

60 enrolled

Tumor-Agnostic

Neoplasms

Clinical Trials

Dasatinib in Combination With Bevacizumab to Treat Advanced Solid Tumors

Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)

Phase I (PH I) Mad Refractory Solid Tumor Study

Study of Dasatinib in Patients With Advanced Solid Tumors